Our results, if validated in animal models, could provide insights into the mechanism driving glomerular degeneration in INF2-linked FSGS and may suggest potential therapeutic strategies for impeding FSGS progression. This evidence concerns the gene INF2 and focal segmental glomerulosclerosis.